Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation
Caterina Gregorio(University of Trieste), Francesca Ieva(Humanitas University), Saverio D’Amico(Istituti di Ricovero e Cura a Carattere Scientifico), Pierre Fenaux(Saint Louis University Hospital), Torsten Haferlach(Martin Luther Christian University), Cristina Astrid Tentori(Humanitas University), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Uwe Platzbecker(National Center for Tumor Diseases), Marta Spreafico(Leiden University), Luca Lanino(Humanitas University), Matteo Giovanni Della Porta(Humanitas University), Elisabetta Sauta(IRCCS Humanitas Research Hospital), Gianluca Asti(IRCCS Humanitas Research Hospital), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 4
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k